Dr. Brian Betts, MD

• Hematology

• Oncology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Memorial Sloan Kettering Cancer Center - Hematology/oncology

  Fellowship Hospital

• University Of Minnesota - Internal Medicine

  Residency Hospital

• Eastern Virginia Medical School

  Medical School, 2004

• Objective and subjective physical function in allogeneic hematopoietic stem cell transplant recipients, 2021-08-11

• Human effectors of acute and chronic GVHD overexpress CD83 and predict mortality, 2023-03-14

• Editorial: Pathogenesis and Therapy of Graft-versus-Host Disease, 2019-07-31

• Clarifying the translational potential of B-I09, 2020-11-01

• Pacritinib combined with sirolimus and low-dose tacrolimus for GVHD prevention after allogeneic hematopoietic cell transplantation: Preclinical and Phase I trial results, 2021-03-22

• Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity, 2018-12-06

• Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft-versus-Host Disease: Phase I Trial Results, 2015-03-21

• Decreased Suppression and Increased Phosphorylated STAT3 in Regulatory T-cells are Associated with Benefit from Adjuvant PD-1 Blockade in Resected Metastatic Melanoma, 2018-08-21

• The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease, 2019-05-08

• Tolerance Associated Gene Expression following Allogeneic Hematopoietic Cell Transplantation, 2015-03-16

• Sole Upfront Therapy with Beclomethasone and Budesonide for Upper Gastrointestinal Acute Graft-versus-Host Disease, 2020-04-30

• Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade, 2016-12-06

• Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining Tregand antitumor CTL function, 2017-01-11

• Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in GVHD Risk Without Increased Relapse Risk Compared to Historical Cyclosporine/Methotrexate, 2023-03-29

• Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant, 2021-01-08

• Dual JAK2/Aurora kinase A inhibition prevents human skin graft rejection by allo-inactivation and ILC2-mediated tissue repair, 2021-11-08

• High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group, 2021-05-18

• Current Concepts and Advances in Graft-Versus-Host Disease Immunology, 2021-01-11

• Human Herpesvirus 6 Infection after Hematopoietic Cell Transplantation: Is Routine Surveillance Necessary?, 2011-04-20